Similar articles

• Bone histomorphometry in patients with chronic renal failure: effect of 1alpha-hydroxyvitamin D3.

  Melsen F, Nielsen HE, Christensen MS. Melsen F, et al. Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:39s-44s. doi: 10.1111/j.1365-2265.1977.tb03360.x. Clin Endocrinol (Oxf). 1977. PMID: 606423
• Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.

  Madsen S. Madsen S. Acta Med Scand Suppl. 1980;638:3-120. Acta Med Scand Suppl. 1980. PMID: 6929650 No abstract available.
• Effects of 1alpha-hydroxyvitamin D3 on serum calcium and immunoreactive parathyroid hormone in patients with chronic renal insufficiency.

  Pietrek J, Kokot F, Kuska J. Pietrek J, et al. Int Urol Nephrol. 1978;10(2):153-60. doi: 10.1007/BF02082136. Int Urol Nephrol. 1978. PMID: 700946
• The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.

  Voigts AL, Felsenfeld AJ, Llach F. Voigts AL, et al. Arch Intern Med. 1983 Jun;143(6):1205-11. Arch Intern Med. 1983. PMID: 6344827 Review.
• 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.

  Brandi L. Brandi L. Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.